NIH Weekly Funding Opportunities and Policy Notices

Notice of Clarification to NIEHS' Participation in PA-23-230 "PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"
Thursday, January 18, 2024 - 10:15am
Notice NOT-ES-24-006 from the NIH Guide for Grants and Contracts
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Thursday, January 18, 2024 - 9:46am
Funding Opportunity PAR-24-122 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.
Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-185 and PAR-21-186
Thursday, January 18, 2024 - 7:27am
Notice NOT-DC-24-020 from the NIH Guide for Grants and Contracts
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
Thursday, January 18, 2024 - 7:12am
Funding Opportunity PAR-24-114 from the NIH Guide for Grants and Contracts. The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC), as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including "low-income," "lower-middle-income," and "upper-middle-income" countries) leading to an independently-funded research career focused on global health. This Funding Opportunity Announcement (FOA) invites applications from postdoctoral research scientists and junior faculty from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC under the mentorship of LMIC and U.S. mentors.
Notice of Participation of the NIMHD in PAR-24-080, "Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)"
Wednesday, January 17, 2024 - 11:17pm
Notice NOT-MD-24-005 from the NIH Guide for Grants and Contracts
Notice of Need to Expire and Reissue NOT-AT-21-014 "Notice of Special Interest: NCCIH T32 Complementary and Integrative Health Practitioner Supplement Program for Pre- and Postdoctoral Candidates" to Change Due Dates
Wednesday, January 17, 2024 - 11:08pm
Notice NOT-AT-24-030 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
Wednesday, January 17, 2024 - 9:41am
Notice NOT-OD-24-044 from the NIH Guide for Grants and Contracts
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Wednesday, January 17, 2024 - 12:16am
Funding Opportunity RFA-DA-25-060 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Notice of Change: Extension of PAR-21-122, PAR-21-123, PAR-21-124 Innovation Grants to Nurture Initial Translational Efforts (IGNITE) NOFOs by One Additional Council Round
Tuesday, January 16, 2024 - 9:55am
Notice NOT-NS-24-048 from the NIH Guide for Grants and Contracts
Notice of Change: Extension of PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)"
Tuesday, January 16, 2024 - 9:39am
Notice NOT-NS-24-040 from the NIH Guide for Grants and Contracts
Notice of Extension to PAR-21-130, PAR-21-131, PAR-21-132, PAR-21-133, PAR-21-134, PAR-21-135, PAR-21-136 and PAR-21-137
Tuesday, January 16, 2024 - 9:26am
Notice NOT-MH-24-155 from the NIH Guide for Grants and Contracts
NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis Phenotyping (APS) Consortium
Tuesday, January 16, 2024 - 2:36am
Notice NOT-GM-24-018 from the NIH Guide for Grants and Contracts
Notice of NIDCD Participation in PAR-23-298 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Tuesday, January 16, 2024 - 1:33am
Notice NOT-DC-24-018 from the NIH Guide for Grants and Contracts
Notice of NIDCD Participation in PAR-23-299 Research to Improve Native American Health (R21 Clinical Trials Optional)
Tuesday, January 16, 2024 - 1:19am
Notice NOT-DC-24-017 from the NIH Guide for Grants and Contracts
Notice of Change: Extension of PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)" by two council rounds
Thursday, January 11, 2024 - 11:56pm
Notice NOT-NS-24-033 from the NIH Guide for Grants and Contracts
Notice of Participation of the All of Us Research Program in PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp-Clinical Trial Not Allowed)
Thursday, January 11, 2024 - 11:16pm
Notice NOT-PM-24-002 from the NIH Guide for Grants and Contracts
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
Thursday, January 11, 2024 - 11:11pm
Funding Opportunity RFA-HG-24-013 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for renewal of the NHGRI Technology Development Coordinating Center (TDCC). The TDCC will continue to provide an infrastructure for enhancing and advancing efforts supported by NHGRIs Genome Technology Program. The Centers activities will include facilitating opportunities for new research collaborations to advance technology development and dissemination. The TDCC will also develop outreach strategies and resources to engage the broader biomedical research community and provide an Opportunity Funds Program to support innovative small-scale work.
Notice of Change to Open Date for PAR-24-048, "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)"
Thursday, January 11, 2024 - 10:47am
Notice NOT-DA-23-051 from the NIH Guide for Grants and Contracts
Notice of Change to Application Due Date for RFA-DA-22-040, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)"
Thursday, January 11, 2024 - 9:29am
Notice NOT-DA-23-041 from the NIH Guide for Grants and Contracts
Topic Areas of Interest for Joint NIH/NSF Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO) Program
Thursday, January 11, 2024 - 9:16am
Notice NOT-GM-24-020 from the NIH Guide for Grants and Contracts

Pages